110 related articles for article (PubMed ID: 2444889)
1. Different rhinovirus serotypes neutralized by antipeptide antibodies.
McCray J; Werner G
Nature; 1987 Oct 22-28; 329(6141):736-8. PubMed ID: 2444889
[TBL] [Abstract][Full Text] [Related]
2. Docking of a human rhinovirus neutralizing antibody onto the viral capsid.
Tormo J; Centeno NB; Fontana E; Bubendorfer T; Fita I; Blaas D
Proteins; 1995 Dec; 23(4):491-501. PubMed ID: 8749845
[TBL] [Abstract][Full Text] [Related]
3. Structure of human rhinovirus serotype 2 (HRV2).
Verdaguer N; Blaas D; Fita I
J Mol Biol; 2000 Jul; 300(5):1179-94. PubMed ID: 10903863
[TBL] [Abstract][Full Text] [Related]
4. A disulfide-bound HIV-1 V3 loop sequence on the surface of human rhinovirus 14 induces neutralizing responses against HIV-1.
Zhang A; Geisler SC; Smith AD; Resnick DA; Li ML; Wang CY; Looney DJ; Wong-Staal F; Arnold E; Arnold GF
Biol Chem; 1999 Mar; 380(3):365-74. PubMed ID: 10223339
[TBL] [Abstract][Full Text] [Related]
5. Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region.
Kondo K; Ishii Y; Ochi H; Matsumoto T; Yoshikawa H; Kanda T
Virology; 2007 Feb; 358(2):266-72. PubMed ID: 17010405
[TBL] [Abstract][Full Text] [Related]
6. Identification of serotype-specific and nonserotype-specific B-cell epitopes of coxsackie B virus using synthetic peptides.
Haarmann CM; Schwimmbeck PL; Mertens T; Schultheiss HP; Strauer BE
Virology; 1994 May; 200(2):381-9. PubMed ID: 7513917
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies to an Indian strain of type A foot-and-mouth disease virus.
Tosh C; Venkataramanan R; Pattnaik B; Hemadri D; Sanyal A
Acta Virol; 1999 Aug; 43(4):219-25. PubMed ID: 10749367
[TBL] [Abstract][Full Text] [Related]
8. Mutational analysis of a neutralization epitope on the dengue type 2 virus (DEN2) envelope protein: monoclonal antibody resistant DEN2/DEN4 chimeras exhibit reduced mouse neurovirulence.
Hiramatsu K; Tadano M; Men R; Lai CJ
Virology; 1996 Oct; 224(2):437-45. PubMed ID: 8874504
[TBL] [Abstract][Full Text] [Related]
9. A 10-amino-acid linear sequence of VP1 of foot and mouth disease virus containing B- and T-cell epitopes induces protection in mice.
Zamorano P; Wigdorovitz A; Perez-Filgueira M; Carrillo C; Escribano JM; Sadir AM; Borca MV
Virology; 1995 Oct; 212(2):614-21. PubMed ID: 7571431
[TBL] [Abstract][Full Text] [Related]
10. The molecular biology of human rhinoviruses.
Skern T; Duechler M; Sommergruber W; Blaas D; Kuechler E
Biochem Soc Symp; 1987; 53():63-73. PubMed ID: 2847742
[TBL] [Abstract][Full Text] [Related]
11. Escape mutants of foot-and-mouth disease virus selected by monoclonal antibodies directed to a trypsin-sensitive neutralization epitope.
Das BR; Pattnaik B; Venkataramanan R; Rai DV
Acta Virol; 1997 Jun; 41(3):131-8. PubMed ID: 9385400
[TBL] [Abstract][Full Text] [Related]
12. Broad antigenic relationships among rhinovirus serotypes revealed by cross-immunization of rabbits with different serotypes.
Cooney MK; Wise JA; Kenny GE; Fox JP
J Immunol; 1975 Feb; 114(2 Pt 1):635-9. PubMed ID: 47360
[TBL] [Abstract][Full Text] [Related]
13. Neutralizing antibodies to human rhinovirus produced in laboratory animals and humans that recognize a linear sequence from VP2.
Hastings GZ; Speller SA; Francis MJ
J Gen Virol; 1990 Dec; 71 ( Pt 12)():3055-9. PubMed ID: 1703215
[TBL] [Abstract][Full Text] [Related]
14. A neutralizing epitope on human rhinovirus type 2 includes amino acid residues between 153 and 164 of virus capsid protein VP2.
Skern T; Neubauer C; Frasel L; Gründler P; Sommergruber W; Zorn M; Kuechler E; Blaas D
J Gen Virol; 1987 Feb; 68 ( Pt 2)():315-23. PubMed ID: 2434607
[TBL] [Abstract][Full Text] [Related]
15. Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides.
Foo DG; Alonso S; Phoon MC; Ramachandran NP; Chow VT; Poh CL
Virus Res; 2007 Apr; 125(1):61-8. PubMed ID: 17222936
[TBL] [Abstract][Full Text] [Related]
16. Structure of a neutralizing antibody bound bivalently to human rhinovirus 2.
Hewat EA; Blaas D
EMBO J; 1996 Apr; 15(7):1515-23. PubMed ID: 8612574
[TBL] [Abstract][Full Text] [Related]
17. Protein engineering to create biologically active peptides: recombinant human rhinoviruses that display peptide sequences.
Smith AD; Arnold E; Arnold GF
Behring Inst Mitt; 1997 Feb; (98):229-39. PubMed ID: 9382744
[TBL] [Abstract][Full Text] [Related]
18. Antigenic sites on the receptor-binding domain of human adenovirus type 2 fiber.
Fender P; Kidd AH; Brebant R; Oberg M; Drouet E; Chroboczek J
Virology; 1995 Dec; 214(1):110-7. PubMed ID: 8525605
[TBL] [Abstract][Full Text] [Related]
19. Conformational flexibility in a highly mobile protein loop of foot-and-mouth disease virus: distinct structural requirements for integrin and antibody binding.
Feliu JX; Benito A; Oliva B; Avilés FX; Villaverde A
J Mol Biol; 1998 Oct; 283(2):331-8. PubMed ID: 9769208
[TBL] [Abstract][Full Text] [Related]
20. Development of cowpea mosaic virus as a high-yielding system for the presentation of foreign peptides.
Porta C; Spall VE; Loveland J; Johnson JE; Barker PJ; Lomonossoff GP
Virology; 1994 Aug; 202(2):949-55. PubMed ID: 8030255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
